Surgeons at Rambam Medical Center conducted the first implant of a synthetic cornea from Israel’s CorNeat (reported here previously). 78-year-old Israeli Arab Jamal from Haifa was able to see clearly immediately after the transplant, for the first time in 10 … Continue reading →

Instead of open-heart surgery, doctors at Jerusalem’s Shaare Zedek Medical Center performed the world’s first catheterizations to unblock heart valves, including of a 96-year-old woman. They used the “ShortCut” – a tiny knife inside a catheter, developed together with Israeli … Continue reading →

This article describes the work of 3 Israeli scientists who received grants from the Israel Cancer Research Fund to research pancreatic cancer therapies. They include cell profiling to find early-stage markers; how glucose affects resistance; and cancer spreading along nerve … Continue reading →

Israel’s Biond Biologics (reported here previously) has signed an exclusive worldwide license agreement with Sanofi for its innovative cancer therapies. Biond will receive $125 million up-front with more than $1 billion in potential payments. Biond’s plans BND-22 human trials to … Continue reading →

Israel’s OncoHost (reported here previously) has achieved about 90% accuracy in predicting how melanoma and lung cancer patients respond to various therapies. And now Israeli Nobel Prize winner Professor Aaron Ciechanover has joined OncoHost’s scientific advisory board. https://www.prnewswire.com/il/news-releases/oncohost-welcomes-nobel-prize-winner-to-scientific-advisory-board-301205142.html https://jitc.bmj.com/content/8/Suppl_3/A11.2 https://www.timesofisrael.com/spotlight/nobel-prizewinner-ciechanover-hails-much-more-precise-cancer-treatment/ … Continue reading →

Researchers at Israel’s Technion Institute have developed a way to detect heart problems based on routine electrocardiography (ECG). The new system demonstrated 96 percent average accuracy in diagnosing the various conditions, compared to 80% for currently available algorithms. https://www.israel21c.org/automated-analysis-of-routine-ecg-detects-cardiac-problems/ https://www.nature.com/articles/s41598-020-73060-w

Israel’s Novel Concepts Medical claims to have developed a combination of natural compounds that significantly decreases the amount of coronavirus spike protein, which binds the virus to the lungs. If its US patent application is approved, it will progress to … Continue reading →

The Nitric Oxide Nasal Spray, developed by Israeli-founded, Canada-based SaNOtize (reported here previously) has proved 99.9% effective in lab tests by Utah State University’s Antiviral Research Institute. Phase 2 trials continue in Canada and are just beginning in UK hospitals. … Continue reading →